6Everson G,Lasseter K C,Anderson K E,et al.The pharmacokonetics of Ziprasidone in subjects with normal and impaired hepatic function[J].Br J Clin Pharmacol,2000,49(Suppl 1):S21 -S26.
8Stimmel G L,Guitierre M A,Lee V.Ziprasidone:an atypical antipsychotic drug for the treatment of schizophrenia[J].Clincal Therapeutics,2002,24 (1):21-37.
2Capuano B, Crosby IT, Lloyd EJ. Schizophrenia: genesis, receptorology and current herapeutics[ J ]. Curr Med Chem, 2002,9(5) : 521 - 548.
3Schmidt AW, Lebel LA, Howard HR Jr, et al. Ziprasidone: a novel antipsychotic agent with aunique human receptor binding profile[ J ]. Eur J Pharmacol, 2001,425 (3) : 197 - 201.
4Miceli JJ, Wilner KD, Hansen RA, et al. Single- and multipledose pharrnacokinetics of 2iprasidone under non-fasting conditions in healthy male volunteers [ J ]. Br J Clin Pharmacol, 2000,49(Suppl 1) :S5 - S13.
5Miceli JJ,Hunt T,Cole MJ, et al. The pharmacokinetics of CP-88,059 in healthy male volunteers following oral and intravenous administration(abstract) [ J ]. Clin Pharmacol Ther, 1994,62 :142.
6Prakash C,Kamel A,Gummerus J, et al. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans[J].Drug Metab Dispos, 1997,25(7) :863 - 872.
7Wilner KD, Tensfeldt TG, Baris B, et al. Single- and multipledose pharmacokinetics of ziprasidone in healthy young and elderly volunteers[J]. Br J Clin Pharmacol,2000,49(Suppl 1 ) : S15 -S20.
8Aweeka F, Jayesekara D, Horton M, et al. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function[J]. Br J Clin Pharmacol,2000,49(Suppl 1) :S27 - S33.
9Everson G, Lasseter KC, Anderson KE, et al. The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function[J]. Br J Clin Pharmacol, 2000,49 ( Suppl 1 ) : S21 -S26.
10Miceli J J, Anziano RJ, Robarge L, et al. The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers [ J ]. Br J Clin Pharmacol, 2000, 49 ( Suppl1) :S65 - S70.
5Keck ME, Mailer MB, Binder EB, et al. Ziprasidone - related tardive dyskinesia. Am J Psychiatry, 2004,161 ( 1 ) : 175 - 176.
6Rosenquist KJ , Walker SS , Ghaemi SN . Tardive dyskinesia and ziprasidone. Am J Psychiatry, 2002,159(8) :1436.
7Ananth J, Burgoyne KS, Niz D, et al. Tardive dyskinesia in 2 patients treated with ziprasidone. J Psychiatry Neurosci, 2004,29 (6) :467 - 469.
8Sharma A, Ramaswamy S, Dewan VK. Resolution of ziprasidone - related tardive dyskinesia with a switch to aripiprazole. Prim Care Companion J Clin Psychiatry, 2005,7( 1 ) :36.
9Ching - Shu Tsai, Yu Lee, Yung - Yee Chang, et al. Ziprasidone - induced tardive laryngeal dystonia: a case report. General Hospital Psychiatry, 2008,30 : 277 - 279.
